09:41 AM EDT, 08/08/2024 (MT Newswires) -- LifeStance Health ( LFST ) reported a Q2 net loss Thursday of $0.06 per diluted share, narrower than a per-share loss of $0.13 a year earlier.

Analysts polled by Capital IQ expected a per-share loss of $0.06.

Revenue for the quarter ended June 30 was $312.3 million, up from $259.6 million a year earlier.

Analysts surveyed by Capital IQ expected $305.3 million.

The company said it expects Q3 revenue between $290 million and $310 million.

Analysts polled by Capital IQ expect $300.4 million.

The company said it raised its full-year 2024 revenue guidance to between $1.20 billion and $1.24 billion. The previous guidance was revenue between $1.19 billion and $1.24 billion.

Analysts polled by Capital IQ expect $1.22 billion.

Price: 5.65, Change: +0.14, Percent Change: +2.54